JLL Partners, a New York middle-market firm with nearly four decades of history, closed its ninth fund at approximately $1.4 billion — meaningfully above its target and roughly 60% larger than Fund VIII’s $866 million. The fund targets healthcare, industrials, and business services and has already made four investments: Vascular Technology, Solvias, Talica, and PowerParts Group. Managing Partners Dan Agroskin, Kevin Hammond, and Frank Rodriguez issued a joint statement on the close. Weil, Gotsha...
Continue Reading
Sign up for FREE to read the full article and access 143K+ alternative investment headlines.
